Condition
Central Core Disease
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT00272883RecruitingPrimary
Molecular and Genetic Studies of Congenital Myopathies
NCT06791369Not Yet Recruiting
The Prevalence of RYR1-related Disease
NCT06157268RecruitingPrimary
The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.
Showing all 3 trials